For biomarker-driven precision medicine clinical trials, the increased importance of samples (biospecimens) has resulted in an increase in trial complexity and operational burden for the sponsors and their lab partners.
Download Document
Related Insights
Managing Informed Consent Samples from Clinical Trials
A set of best practices for the definition, tracking and management of allowable use attributes associated with samples collected in protocol based clinical trials
Consent Tracking for Clinical Trial Samples
Optimizing the management of consents throughout the entire lifecycle
Tracking Clinical Trial Samples
Optimizing the management of samples throughout the entire lifecycle
Blockchain in Clinical Research Sample Management
Distributed Ledger Technology (DLT) in clinical trials
Managing Sample Data from Vendors
Best Practices for Clinical Trials
Managing Sample Data from Vendors
Best practices for clinical trials
eConsent and BioBanking
How to reduce costs while improving efficiencies
Key Central Laboratory Capabilities to Enable Successful Immuno-Oncology Clinical Development
Trends and recommendations in laboratory selection
Best practices in clinical trial sample and consent lifecycle management
Clinical Trial Biospecimen and Consent Tracking
Learn about the BioFortis solution for addressing new challenges around sample and consent tracking
